Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. PureTech Share Price
  4. PureTech Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksPureTech Regulatory News (PRTC)

PureTech Information

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
126.20    -0.40 (-0.32%)
Bid:
125.20
Ask:
125.80
Spread: 0.60 (0.479%)
Market Cap: £307.19m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

22 Jun 2022 07:00

RNS Number : 7610P
PureTech Health PLC
22 June 2022
 

22 June 2022

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

21 June 2022

Number of ordinary shares purchased:

35,858

Highest price paid per share:

162.80p

Lowest price paid per share:

162.20p

Volume weighted average price paid per share:

162.79p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 1,395,258 ordinary shares in treasury and has 287,215,862 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 287,215,862, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders.

This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

 

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

21/06/2022

16:29:59

989

162.8

XLON

00306410243TRLO1.1.1

21/06/2022

16:02:43

346

162.8

TRQX

00306398882TRLO1.1.1

21/06/2022

15:39:03

18

162.8

TRQX

00306387336TRLO1.1.1

21/06/2022

15:39:03

22

162.8

TRQX

00306387337TRLO1.1.1

21/06/2022

15:39:03

19

162.8

TRQX

00306387335TRLO1.1.1

21/06/2022

15:39:03

11

162.8

TRQX

00306387334TRLO1.1.1

21/06/2022

15:39:03

18

162.8

TRQX

00306387333TRLO1.1.1

21/06/2022

15:39:03

18

162.8

TRQX

00306387331TRLO1.1.1

21/06/2022

15:39:03

176

162.8

TRQX

00306387332TRLO1.1.1

21/06/2022

15:39:03

22

162.8

TRQX

00306387330TRLO1.1.1

21/06/2022

15:39:03

21

162.8

TRQX

00306387329TRLO1.1.1

21/06/2022

15:39:03

21

162.8

TRQX

00306387328TRLO1.1.1

21/06/2022

15:39:03

4

162.8

TRQX

00306387327TRLO1.1.1

21/06/2022

15:39:02

31

162.8

BATE

00306387323TRLO1.1.1

21/06/2022

15:39:02

18

162.8

TRQX

00306387322TRLO1.1.1

21/06/2022

15:39:02

2

162.8

TRQX

00306387321TRLO1.1.1

21/06/2022

15:39:02

9

162.8

BATE

00306387320TRLO1.1.1

21/06/2022

15:39:02

18

162.8

BATE

00306387319TRLO1.1.1

21/06/2022

15:39:02

8

162.8

CHIX

00306387317TRLO1.1.1

21/06/2022

15:39:02

17

162.8

BATE

00306387318TRLO1.1.1

21/06/2022

15:39:02

8

162.8

CHIX

00306387316TRLO1.1.1

21/06/2022

15:39:02

18

162.8

CHIX

00306387315TRLO1.1.1

21/06/2022

15:39:02

16

162.8

CHIX

00306387314TRLO1.1.1

21/06/2022

15:39:02

29

162.8

CHIX

00306387313TRLO1.1.1

21/06/2022

15:39:02

5

162.8

BATE

00306387312TRLO1.1.1

21/06/2022

15:39:02

9

162.8

BATE

00306387310TRLO1.1.1

21/06/2022

15:39:02

10

162.8

BATE

00306387311TRLO1.1.1

21/06/2022

15:39:02

5

162.8

BATE

00306387309TRLO1.1.1

21/06/2022

15:39:02

11

162.8

BATE

00306387308TRLO1.1.1

21/06/2022

15:39:02

14

162.8

BATE

00306387307TRLO1.1.1

21/06/2022

15:39:02

15

162.8

BATE

00306387306TRLO1.1.1

21/06/2022

15:39:02

50

162.8

AQXE

00306387303TRLO1.1.1

21/06/2022

15:39:02

32

162.8

CHIX

00306387305TRLO1.1.1

21/06/2022

15:39:02

23

162.8

CHIX

00306387304TRLO1.1.1

21/06/2022

15:39:02

48

162.8

AQXE

00306387301TRLO1.1.1

21/06/2022

15:39:02

51

162.8

AQXE

00306387302TRLO1.1.1

21/06/2022

15:39:02

53

162.8

AQXE

00306387299TRLO1.1.1

21/06/2022

15:39:02

51

162.8

AQXE

00306387300TRLO1.1.1

21/06/2022

15:39:02

59

162.8

AQXE

00306387297TRLO1.1.1

21/06/2022

15:39:02

53

162.8

AQXE

00306387298TRLO1.1.1

21/06/2022

15:39:02

12

162.8

AQXE

00306387296TRLO1.1.1

21/06/2022

15:39:02

17

162.8

CHIX

00306387295TRLO1.1.1

21/06/2022

15:35:09

43

162.8

AQXE

00306385830TRLO1.1.1

21/06/2022

15:35:09

51

162.8

AQXE

00306385829TRLO1.1.1

21/06/2022

15:35:09

50

162.8

AQXE

00306385828TRLO1.1.1

21/06/2022

15:35:09

55

162.8

AQXE

00306385827TRLO1.1.1

21/06/2022

15:35:09

51

162.8

AQXE

00306385826TRLO1.1.1

21/06/2022

15:35:09

44

162.8

AQXE

00306385825TRLO1.1.1

21/06/2022

15:34:48

6

162.8

AQXE

00306385633TRLO1.1.1

21/06/2022

15:34:48

50

162.8

AQXE

00306385632TRLO1.1.1

21/06/2022

15:34:48

48

162.8

AQXE

00306385631TRLO1.1.1

21/06/2022

15:34:48

51

162.8

AQXE

00306385630TRLO1.1.1

21/06/2022

15:34:48

53

162.8

AQXE

00306385629TRLO1.1.1

21/06/2022

15:34:48

107

162.8

AQXE

00306385628TRLO1.1.1

21/06/2022

14:53:03

870

162.8

XLON

00306363699TRLO1.1.1

21/06/2022

14:53:00

1000

162.8

XLON

00306363665TRLO1.1.1

21/06/2022

14:52:59

1000

162.8

XLON

00306363657TRLO1.1.1

21/06/2022

14:50:02

740

162.8

XLON

00306361855TRLO1.1.1

21/06/2022

14:50:02

110

162.8

XLON

00306361854TRLO1.1.1

21/06/2022

14:50:01

1000

162.8

XLON

00306361850TRLO1.1.1

21/06/2022

14:50:01

1000

162.8

XLON

00306361849TRLO1.1.1

21/06/2022

14:50:01

1000

162.8

XLON

00306361846TRLO1.1.1

21/06/2022

14:50:00

1000

162.8

XLON

00306361837TRLO1.1.1

21/06/2022

14:50:00

1000

162.8

XLON

00306361836TRLO1.1.1

21/06/2022

14:50:00

345

162.8

AQXE

00306361832TRLO1.1.1

21/06/2022

14:49:59

1000

162.8

XLON

00306361828TRLO1.1.1

21/06/2022

14:49:58

1000

162.8

XLON

00306361827TRLO1.1.1

21/06/2022

14:49:58

2592

162.8

XLON

00306361826TRLO1.1.1

21/06/2022

14:49:58

449

162.8

AQXE

00306361825TRLO1.1.1

21/06/2022

14:49:58

32

162.8

BATE

00306361824TRLO1.1.1

21/06/2022

14:49:58

66

162.8

BATE

00306361823TRLO1.1.1

21/06/2022

14:49:58

389

162.8

BATE

00306361821TRLO1.1.1

21/06/2022

14:49:58

73

162.8

BATE

00306361822TRLO1.1.1

21/06/2022

14:49:58

21

162.8

TRQX

00306361820TRLO1.1.1

21/06/2022

14:49:58

22

162.8

TRQX

00306361819TRLO1.1.1

21/06/2022

14:49:58

20

162.8

TRQX

00306361818TRLO1.1.1

21/06/2022

14:49:58

20

162.8

TRQX

00306361817TRLO1.1.1

21/06/2022

14:49:58

18

162.8

TRQX

00306361815TRLO1.1.1

21/06/2022

14:49:58

18

162.8

TRQX

00306361816TRLO1.1.1

21/06/2022

14:49:58

16

162.8

TRQX

00306361814TRLO1.1.1

21/06/2022

14:49:58

21

162.8

TRQX

00306361813TRLO1.1.1

21/06/2022

14:49:58

20

162.8

TRQX

00306361812TRLO1.1.1

21/06/2022

14:49:58

20

162.8

TRQX

00306361811TRLO1.1.1

21/06/2022

14:49:58

19

162.8

TRQX

00306361809TRLO1.1.1

21/06/2022

14:49:58

18

162.8

TRQX

00306361810TRLO1.1.1

21/06/2022

14:49:58

22

162.8

TRQX

00306361808TRLO1.1.1

21/06/2022

14:49:58

22

162.8

TRQX

00306361807TRLO1.1.1

21/06/2022

14:49:58

22

162.8

TRQX

00306361806TRLO1.1.1

21/06/2022

14:49:58

377

162.6

XLON

00306361805TRLO1.1.1

21/06/2022

14:49:58

72

162.8

BATE

00306361803TRLO1.1.1

21/06/2022

14:49:58

20

162.8

TRQX

00306361804TRLO1.1.1

21/06/2022

14:49:58

229

162.8

XLON

00306361801TRLO1.1.1

21/06/2022

14:49:58

187

162.8

BATE

00306361802TRLO1.1.1

21/06/2022

14:49:58

263

162.8

XLON

00306361800TRLO1.1.1

21/06/2022

14:49:58

9964

162.8

XLON

00306361799TRLO1.1.1

21/06/2022

14:49:58

244

162.8

XLON

00306361798TRLO1.1.1

21/06/2022

14:49:58

250

162.8

XLON

00306361797TRLO1.1.1

21/06/2022

14:49:58

244

162.8

XLON

00306361796TRLO1.1.1

21/06/2022

14:49:58

221

162.8

XLON

00306361795TRLO1.1.1

21/06/2022

14:49:58

213

162.8

XLON

00306361794TRLO1.1.1

21/06/2022

14:49:58

213

162.8

XLON

00306361792TRLO1.1.1

21/06/2022

14:49:58

240

162.8

XLON

00306361793TRLO1.1.1

21/06/2022

14:49:58

253

162.8

XLON

00306361791TRLO1.1.1

21/06/2022

14:49:58

237

162.8

XLON

00306361789TRLO1.1.1

21/06/2022

14:49:58

257

162.8

XLON

00306361790TRLO1.1.1

21/06/2022

14:49:58

226

162.8

XLON

00306361788TRLO1.1.1

21/06/2022

14:49:58

259

162.8

XLON

00306361787TRLO1.1.1

21/06/2022

14:49:58

226

162.8

XLON

00306361785TRLO1.1.1

21/06/2022

14:49:58

247

162.8

XLON

00306361786TRLO1.1.1

21/06/2022

14:49:58

249

162.8

XLON

00306361783TRLO1.1.1

21/06/2022

14:49:58

218

162.8

XLON

00306361784TRLO1.1.1

21/06/2022

14:49:58

239

162.8

XLON

00306361781TRLO1.1.1

21/06/2022

14:49:58

227

162.8

XLON

00306361782TRLO1.1.1

21/06/2022

14:49:58

7

162.8

XLON

00306361779TRLO1.1.1

21/06/2022

14:49:58

227

162.8

XLON

00306361780TRLO1.1.1

21/06/2022

14:49:58

216

162.8

XLON

00306361777TRLO1.1.1

21/06/2022

14:49:58

229

162.8

XLON

00306361778TRLO1.1.1

21/06/2022

14:49:58

254

162.8

XLON

00306361775TRLO1.1.1

21/06/2022

14:49:58

227

162.8

XLON

00306361776TRLO1.1.1

21/06/2022

14:49:58

74

162.8

XLON

00306361774TRLO1.1.1

21/06/2022

14:49:55

143

162.8

XLON

00306361768TRLO1.1.1

21/06/2022

14:49:55

407

162.8

XLON

00306361767TRLO1.1.1

21/06/2022

09:46:20

662

162.6

XLON

00306289203TRLO1.1.1

21/06/2022

09:46:18

5

162.2

TRQX

00306289199TRLO1.1.1

21/06/2022

09:46:18

30

162.2

TRQX

00306289198TRLO1.1.1

21/06/2022

09:46:18

31

162.2

TRQX

00306289196TRLO1.1.1

21/06/2022

09:46:18

20

162.2

TRQX

00306289197TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFIFFVRIIFFIF
12345678910
Date   Source Headline
4th Jun 20265:37 pmRNSHolding(s) in Company
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
21st Aug 202512:00 pmRNS-RPureTech Showcases Differentiated IPF Strategy
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
TLOU
TLOU ENERGY
LSE
0.00%
MNKS
Monks Investment Trust
LSE
-1.23%
APTD
Aptitude
LSE
-0.45%
SHEL
Shell
LSE
-0.06%
BGS
Baillie Gifford Shin Nippon PLC
LSE
1.79%
Trending